Vimarsana
Biggest News Aggregation in the World

Page 2 - Client Alerts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Client Alerts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Client Alerts Today - Breaking & Trending Today

Investment Advisers, Broker-Dealers, and Other Financial Industry Participants Take Note: SEC Demonstrates Commitment to Cybersecurity With Three Simultaneous Rule Proposals | Lowenstein Sandler LLP - Vimarsana News

Investment Advisers, Broker-Dealers, and Other Financial Industry Participants Take Note: SEC Demonstrates Commitment to Cybersecurity With Three Simultaneous Rule Proposals | Lowenstein Sandler LLP

On March 15, 2023, the Securities and Exchange Commission (“SEC”) issued three releases proposing (i) amendments to Regulation S-P (“Regulation S-P Proposal”)1, (ii) amendments to...

United States: SEC promotes Order Competition — by limiting it? - Vimarsana News

United States: SEC promotes Order Competition — by limiting it?

On December 14, 2022, the Securities and Exchange Commission (SEC) proposed four separate rulemakings under the Securities Exchange Act of 1934…

SECURE 2.0 Impact for 2023 - Vimarsana News

SECURE 2.0 Impact for 2023

The President signed the SECURE 2.0 Act, which was a part of the Consolidated Appropriations Act of 2023, a must pass appropriations bill. SECURE 2.0 includes more than 90 provisions and effective dates range from immediate to 2033. The Act is 3 times longer than the original.

United States: The Securities and Exchange Commission New Year's resolution? Market restructuring for all! - Vimarsana News

United States: The Securities and Exchange Commission New Year's resolution? Market restructuring for all!

On 14 December 2022, the Securities and Exchange Commission (SEC) proposed four separate rulemakings under the Securities Exchange Act of…

Not Quite the Titanic: The Food and Drug Omnibus Reform Act Rescues Some FDA Policy Initiatives | King & Spalding - Vimarsana News

Not Quite the Titanic: The Food and Drug Omnibus Reform Act Rescues Some FDA Policy Initiatives | King & Spalding

The Food and Drug Administration (“FDA” or the “Agency”) user fee negotiations may have hit an iceberg, but it did not sink all the legislative riders that accompanied this summer’s...